Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Hoyoux

Showing results (51-60 of 58) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 58 results.
Medical and Pediatric Oncology|December 1, 1995
Tropisetron in the prevention of nausea and vomiting in 131 children receiving cytotoxic chemotherapyY Benoit, F Hulstaert, C Vermylen, et al.
Anti-Cancer Drugs|February 1, 1995
Control of nausea and vomiting by Navoban (tropisetron) in 131 children receiving cytotoxic chemotherapyY Benoit, F Hulstaert, C Vermylen, et al.
Archives De Pediatrie : Organe Officiel De La Societe Francaise De Pediatrie|July 30, 2019
A not so harmless mass: Kaposiform hemangioendothelioma complicated by a Kasabach-Merritt phenomenonS Tribolet, C Hoyoux, L M Boon, et al.
Revue Medicale De Liege|January 13, 2006
[Retrospective study of childhood lymphomas. Report of 27 children treated at a single institution]C Kempeneers, P Forget, M F Dresse, et al.
Revue Medicale De Bruxelles|June 5, 2001
[Immune deficiencies: diagnosis, management, some perspectives]C M Farber, Y Benoit, K Boven, et al.
Revue Medicale De Liege|June 15, 2007
[Management of medulloblastoma in children: the experience of a single institution in Liege from 1991 to 2005]A C Fransolet, J D Born, J P Misson, et al.
Archives De Pediatrie : Organe Officiel De La Societe Francaise De Pediatrie|May 26, 2021
CNS-3 status remains an independent adverse prognosis factor in children with acute lymphoblastic leukemia (ALL) treated without cranial irradiation: Results of EORTC Children Leukemia Group study 58951N Sirvent, S Suciu, B De Moerloose, et al.
Leukemia|September 2, 2005
Results of 58872 and 58921 trials in acute myeloblastic leukemia and relative value of chemotherapy vs allogeneic bone marrow transplantation in first complete remission: the EORTC Children Leukemia Group reportN Entz-Werle, S Suciu, J van der Werff ten Bosch, et al.
Pageof 6

Showing results (51-60 of 58) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 58 results.
Medical and Pediatric Oncology|December 1, 1995
Tropisetron in the prevention of nausea and vomiting in 131 children receiving cytotoxic chemotherapyY Benoit, F Hulstaert, C Vermylen, et al.
Anti-Cancer Drugs|February 1, 1995
Control of nausea and vomiting by Navoban (tropisetron) in 131 children receiving cytotoxic chemotherapyY Benoit, F Hulstaert, C Vermylen, et al.
Archives De Pediatrie : Organe Officiel De La Societe Francaise De Pediatrie|July 30, 2019
A not so harmless mass: Kaposiform hemangioendothelioma complicated by a Kasabach-Merritt phenomenonS Tribolet, C Hoyoux, L M Boon, et al.
Revue Medicale De Liege|January 13, 2006
[Retrospective study of childhood lymphomas. Report of 27 children treated at a single institution]C Kempeneers, P Forget, M F Dresse, et al.
Revue Medicale De Bruxelles|June 5, 2001
[Immune deficiencies: diagnosis, management, some perspectives]C M Farber, Y Benoit, K Boven, et al.
Revue Medicale De Liege|June 15, 2007
[Management of medulloblastoma in children: the experience of a single institution in Liege from 1991 to 2005]A C Fransolet, J D Born, J P Misson, et al.
Archives De Pediatrie : Organe Officiel De La Societe Francaise De Pediatrie|May 26, 2021
CNS-3 status remains an independent adverse prognosis factor in children with acute lymphoblastic leukemia (ALL) treated without cranial irradiation: Results of EORTC Children Leukemia Group study 58951N Sirvent, S Suciu, B De Moerloose, et al.
Leukemia|September 2, 2005
Results of 58872 and 58921 trials in acute myeloblastic leukemia and relative value of chemotherapy vs allogeneic bone marrow transplantation in first complete remission: the EORTC Children Leukemia Group reportN Entz-Werle, S Suciu, J van der Werff ten Bosch, et al.
Pageof 6